Verbatim response from Perplexity
Most men should consider enclomiphene first if fertility matters and the goal is to stimulate their own testosterone production rather than replace it. TRT is usually the better first choice when hypogonadism is more severe, symptoms are more urgent, or fertility is not a priority. [1][2][5][7]
- Choose enclomiphene first if you want to preserve fertility, avoid suppressing sperm production, prefer an oral option, and your low testosterone appears to be a situation where your testes can still respond to pituitary stimulation. Enclomiphene raises LH/FSH and encourages the body to make its own testosterone. [1][2][5][7][11]
- Choose TRT first if you have more severe hypogonadism, need a faster and often stronger testosterone rise, or do not care about fertility preservation. TRT is an exogenous hormone replacement and is typically more rapid in onset. [1][3][4][5]
- If you are trying to conceive now or may want kids soon, enclomiphene is generally the more fertility-sparing option; TRT can suppress sperm production and sometimes cause testicular shrinkage. [1][2][3][5][7]
- If your body’s own axis is not likely to respond well, or if prior fertility-sparing approaches have failed, TRT may be more appropriate. [5][7]
A practical way to think about it:
| Situation | Better first consideration |
|---|---|
| Want to preserve fertility | Enclomiphene |
| Need faster symptom relief | TRT |
| Severe/clear hypogonadism | TRT |
| Mild-to-moderate low T with functioning testes | Enclomiphene |
| Want an FDA-approved standard therapy | TRT |
| Prefer an oral medication | Enclomiphene |
Two important caveats:
- Enclomiphene is commonly described as off-label/compounded and has less long-term evidence than TRT. [2][5][7]
- Either option should be chosen based on labs and symptoms, not testosterone alone; monitoring matters for safety and dose adjustment. [7][8]
If you want, I can help you decide which is more likely to fit based on your age, testosterone level, LH/FSH, fertility goals, and symptoms.